Remicade was trumpeted as a wonder drug for rheumatoid arthritis and Crohn's disease when licensed for use six years ago.
The COX-2 inhibitors are not the only arthritis drugs under scrutiny at the moment. The US Food and Drug Administration is also taking a good hard look at the tumour necrosis factor (TNF)-blocking drugs, also used to treat rheumatoid arthritis...